Project Number EUJPND-Hersenstichting-Multiple PI-1643 Agency/Funding Organization Hersenstichting Funding Year 2016 View Full Project Details for De ontwikkeling van een ALS therapie gericht op Ataxine-2. The development of an ALS therapy focused on Ataxin-2 Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category H. Brain Aging and Common Mechanisms related to Dementia 2. Common Mechanisms Related to Dementias c. Clinical Research and Epidemiology Researcher and Organization Principal Investigator Multiple PI Principal Investigator First Name Multiple PI Principal Investigator Last Name Multiple PI Awardee Organization UMCU Contact PI Country The Netherlands Project Detail FY Overall Cost $14,033 Funding Organization Agency/Funding Organization Hersenstichting Funding Organization Country The Netherlands Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)